Keyword: CANbridge Life Sciences
Novartis nabs GSK executive for Sandoz CEO; Pfizer oncology executive hops to Aduro as CMO; and Alkermes' former COO will head up ops at Paragon.
CANbridge Pharmaceutical and CRO WuXi Biologics announced a partnership to develop and market rare disease therapies.
CAR-T maker Cell Medica names Kite’s European chief as CEO; Oncorus poaches a Moderna cancer executive; and Achaogen axes R&D and its C-suite.
Beijing’s CANbridge Life Sciences, developing Western drug candidates in China and Asia, brought on Pfizer’s May Orfali to be chief medical officer.
Lundbeck chief Schultz will lead Teva, former CDC director Frieden leads a new health project, Roivant named Eisai exec Waxman as general counsel.
Beijing-based CANbridge Life Sciences has pulled off a $25 million funding round, bringing its total two rounds up to $40 million as it plans new oncology trials and “additional strategic transactions” this year.